Published in J Clin Oncol on December 01, 1997
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol (2010) 2.66
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clin Cancer Res (2009) 1.47
The role of radiation therapy in the management of sarcomas. Surg Clin North Am (2008) 1.25
Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas. Pediatr Blood Cancer (2012) 1.15
Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas. J Nucl Med (2008) 1.05
The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin. Mar Drugs (2009) 0.92
Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates. Clin Cancer Res (2013) 0.83
Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas. Int J Clin Oncol (2011) 0.79
Prognostic Factors in Indian Patients Operated for Soft Tissue Sarcomas-a Retrospective Cross-sectional Analysis. Indian J Surg Oncol (2016) 0.75
A non-comparative phase II study of dose intensive chemotherapy with doxorubicin and ifosfamide followed by high dose ICE consolidation with PBSCT in non-resectable, high grade, adult type soft tissue sarcomas. Invest New Drugs (2013) 0.75
Yeast mRNA splicing in vitro. J Biol Chem (1985) 5.48
Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med (1988) 5.16
A dust-obscured massive maximum-starburst galaxy at a redshift of 6.34. Nature (2013) 4.43
Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature (1996) 4.42
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med (1988) 4.02
HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA (2000) 3.93
Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg (1992) 3.40
A chromosome bin map of 16,000 expressed sequence tag loci and distribution of genes among the three genomes of polyploid wheat. Genetics (2004) 3.37
Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA (2001) 3.26
Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol (1999) 3.18
Phytochrome E influences internode elongation and flowering time in Arabidopsis. Plant Cell (1998) 3.17
Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev (1995) 3.16
Existence of at least three distinct Alu subfamilies. J Mol Evol (1987) 3.03
Intricate combinatorial patterns of exon splicing generate multiple regulated troponin T isoforms from a single gene. Cell (1985) 3.02
Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med (1996) 2.92
Risk of dissemination of cancer to flap donor sites during immediate reconstructive surgery. Ann Plast Surg (1994) 2.76
Molecular consequences of specific intron mutations on yeast mRNA splicing in vivo and in vitro. Cell (1985) 2.75
EELS log-ratio technique for specimen-thickness measurement in the TEM. J Electron Microsc Tech (1988) 2.72
Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest (1996) 2.68
Indian public-private partnership for skilled birth-attendance. Lancet (2008) 2.65
Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation. Int J Radiat Oncol Biol Phys (1995) 2.61
Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer (1990) 2.56
Primary treatment of cystosarcoma phyllodes of the breast. Cancer (2000) 2.55
Confidence bands for cumulative incidence curves under the additive risk model. Biometrics (1999) 2.52
Phytochrome D acts in the shade-avoidance syndrome in Arabidopsis by controlling elongation growth and flowering time. Plant Physiol (1999) 2.42
Reversibility of muscle differentiation in the absence of commitment: analysis of a myogenic cell line temperature-sensitive for commitment. Cell (1983) 2.37
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22
Submillimetre galaxies reside in dark matter haloes with masses greater than 3 × 10(11) solar masses. Nature (2011) 2.21
Bim1p/Yeb1p mediates the Kar9p-dependent cortical attachment of cytoplasmic microtubules. Mol Biol Cell (2000) 2.17
The lower esophageal sphincter in health and disease. Am J Surg (1988) 2.17
Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer (1974) 2.10
Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer (1992) 2.02
Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin Cancer Res (1997) 2.02
The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy. Int J Radiat Oncol Biol Phys (1995) 2.00
Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol (1999) 1.92
Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer (2001) 1.89
Genetic and clinical predictors of warfarin dose requirements in African Americans. Clin Pharmacol Ther (2010) 1.88
Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol (2001) 1.88
Cef1p is a component of the Prp19p-associated complex and essential for pre-mRNA splicing. J Biol Chem (1999) 1.87
Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys (2000) 1.87
New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol (2008) 1.87
Functional association of essential splicing factor(s) with PRP19 in a protein complex. EMBO J (1994) 1.86
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85
A pilot study of preoperative chemoradiotherapy for resectable gastric cancer. Ann Surg Oncol (2001) 1.85
Transcriptional and cell cycle-mediated regulation of myosin heavy chain gene expression during muscle cell differentiation. J Biol Chem (1983) 1.82
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation (1999) 1.82
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol (2012) 1.81
Yeast precursor mRNA processing protein PRP19 associates with the spliceosome concomitant with or just after dissociation of U4 small nuclear RNA. Proc Natl Acad Sci U S A (1993) 1.77
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. Cancer J Sci Am (1998) 1.77
The yeast PRP19 protein is not tightly associated with small nuclear RNAs, but appears to associate with the spliceosome after binding of U2 to the pre-mRNA and prior to formation of the functional spliceosome. Mol Cell Biol (1993) 1.77
Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol (2001) 1.77
Characterization of sarcomeric myosin heavy chain genes. J Biol Chem (1983) 1.74
Adjuvant radiotherapy for phyllodes tumor of breast. Radiat Oncol Investig (1998) 1.73
A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med (2000) 1.72
A novel mechanism of alternative RNA splicing for the developmentally regulated generation of troponin T isoforms from a single gene. Cell (1984) 1.71
Hemangiopericytoma: a 20-year single-institution experience. Ann Surg Oncol (1998) 1.69
Clinical and radiological evidence to support superficial parotidectomy as the treatment of choice for chronic parotid sialadenitis: a retrospective study. Br J Oral Maxillofac Surg (2001) 1.68
Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 1.67
Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer (2000) 1.67
Cytoplasmic processing of myosin heavy chain messenger RNA: evidence provided by using a recombinant DNA plasmid. Proc Natl Acad Sci U S A (1980) 1.67
Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg (1995) 1.66
Serum testosterone levels after external beam radiation for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (1997) 1.66
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65
Length of the distal esophageal sphincter and competency of the cardia. Am J Surg (1986) 1.64
Lymphocyte subsets in healthy children during the first 5 years of life. JAMA (1992) 1.64
Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys (2003) 1.63
Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst (2000) 1.62
Effect of increased lung volume on sleep disordered breathing in patients with sleep apnoea. Thorax (2006) 1.62
Mapping QTLs associated with drought resistance in sorghum (Sorghum bicolor L. Moench). Plant Mol Biol (2002) 1.61
Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg (1990) 1.59
Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol (1998) 1.58
Fractionation and characterization of a yeast mRNA splicing extract. Proc Natl Acad Sci U S A (1986) 1.56
Providing skilled birth attendants and emergency obstetric care to the poor through partnership with private sector obstetricians in Gujarat, India. Bull World Health Organ (2009) 1.54
Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin. J Infect Dis (1982) 1.53
Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res (2000) 1.53
Serum testosterone--a significant determinant of metastatic relapse for irradiated localized prostate cancer. Urology (1997) 1.52
Mapping osmotic adjustment in an advanced back-cross inbred population of rice. Theor Appl Genet (2003) 1.51
Assessment of the effects of instrumentation, monoclonal antibody, and fluorochrome on flow cytometric immunophenotyping: a report based on 2 years of the NIAID DAIDS flow cytometry quality assessment program. Clin Immunol Immunopathol (1993) 1.50
Sarcomeric myosin heavy chain is coded by a highly conserved multigene family. Proc Natl Acad Sci U S A (1982) 1.50
Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy. Ann Surg Oncol (1999) 1.50
Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg (1986) 1.50
p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proc Natl Acad Sci U S A (1999) 1.48
Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field. Cancer J Sci Am (1999) 1.48
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47
Adriamycin cardiomyopathy--risk factors. Cancer (1977) 1.46
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45